Cargando…

Scintigraphic evaluation of the osteoblastic activity of rabbit tibial defects after HYAFF11 membrane application

BACKGROUND: An unfavorable condition for bone healing is the presence of bone defects. Under such conditions, a material can play a role to cover fractured or defective bone. Technological advances now allow for the use of such material. Hyalonect(®) (Fidia Advanced Biopolymers SLR, Italy), a novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Mermerkaya, Musa Uğur, Doral, Mahmut Nedim, Karaaslan, Fatih, Huri, Gazi, Karacavuş, Seyhan, Kaymaz, Burak, Alkan, Erkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855359/
https://www.ncbi.nlm.nih.gov/pubmed/27142755
http://dx.doi.org/10.1186/s13018-016-0393-y
_version_ 1782430354498387968
author Mermerkaya, Musa Uğur
Doral, Mahmut Nedim
Karaaslan, Fatih
Huri, Gazi
Karacavuş, Seyhan
Kaymaz, Burak
Alkan, Erkan
author_facet Mermerkaya, Musa Uğur
Doral, Mahmut Nedim
Karaaslan, Fatih
Huri, Gazi
Karacavuş, Seyhan
Kaymaz, Burak
Alkan, Erkan
author_sort Mermerkaya, Musa Uğur
collection PubMed
description BACKGROUND: An unfavorable condition for bone healing is the presence of bone defects. Under such conditions, a material can play a role to cover fractured or defective bone. Technological advances now allow for the use of such material. Hyalonect(®) (Fidia Advanced Biopolymers SLR, Italy), a novel membrane comprising knitted fibers of esterified hyaluronan (HYAFF11) can be used to cover fractured or grafted bone and can also serve as a scaffold to keep osteoprogenitor cells in place. The aim of this study was to compare osteoblastic activity by the use of scintigraphic methods in defective rabbit tibias during early-phase bone healing with or without a hyaluronan-based mesh. METHODS: Two groups (A and B) of New Zealand albino rabbits were used; each group included 10 animals. Operations on all rabbits were performed under general anesthesia. We also resected 10-mm bone segments from each animal’s tibial diaphysis. After resection, tibias with defects were fixed using Kirschner wires. In group A, no hyaluronan-based mesh was used. In group B, tibial segmental defects were enclosed with a hyaluronan-based mesh. The rabbits were followed up for 4 weeks postoperatively, after which bone scintigraphic studies were performed on each animal to detect and compare osteoblastic activity. RESULTS: The mean count in the fracture side of the hyaluronan-based mesh group was significantly higher compared to that of the group A (p = 0.019). However, there was no significant difference between group B and control rabbits with respect to the mean count on the intact bone side (p = 0.437). The bone defect (fracture)/intact bone mean count ratio was significantly higher in group B compared to group A (p = 0.008). CONCLUSIONS: A hyaluronan-based mesh plays a role in promoting osteoblastic activity. Hyalonect(®) is suitable for restoring tissue continuity whenever the periosteal membrane is structurally impaired or inadequate. Our results demonstrated that, during early-phase bone healing, osteoblastic activity was increased in bone defect sites when a hyaluronan-based mesh was also used. The most important aspect of this study concerns its scintigraphy-based design. This study is the first to use a scintigraphic method to demonstrate the effectiveness of hyaluronic acid-based material for bone healing.
format Online
Article
Text
id pubmed-4855359
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48553592016-05-05 Scintigraphic evaluation of the osteoblastic activity of rabbit tibial defects after HYAFF11 membrane application Mermerkaya, Musa Uğur Doral, Mahmut Nedim Karaaslan, Fatih Huri, Gazi Karacavuş, Seyhan Kaymaz, Burak Alkan, Erkan J Orthop Surg Res Research Article BACKGROUND: An unfavorable condition for bone healing is the presence of bone defects. Under such conditions, a material can play a role to cover fractured or defective bone. Technological advances now allow for the use of such material. Hyalonect(®) (Fidia Advanced Biopolymers SLR, Italy), a novel membrane comprising knitted fibers of esterified hyaluronan (HYAFF11) can be used to cover fractured or grafted bone and can also serve as a scaffold to keep osteoprogenitor cells in place. The aim of this study was to compare osteoblastic activity by the use of scintigraphic methods in defective rabbit tibias during early-phase bone healing with or without a hyaluronan-based mesh. METHODS: Two groups (A and B) of New Zealand albino rabbits were used; each group included 10 animals. Operations on all rabbits were performed under general anesthesia. We also resected 10-mm bone segments from each animal’s tibial diaphysis. After resection, tibias with defects were fixed using Kirschner wires. In group A, no hyaluronan-based mesh was used. In group B, tibial segmental defects were enclosed with a hyaluronan-based mesh. The rabbits were followed up for 4 weeks postoperatively, after which bone scintigraphic studies were performed on each animal to detect and compare osteoblastic activity. RESULTS: The mean count in the fracture side of the hyaluronan-based mesh group was significantly higher compared to that of the group A (p = 0.019). However, there was no significant difference between group B and control rabbits with respect to the mean count on the intact bone side (p = 0.437). The bone defect (fracture)/intact bone mean count ratio was significantly higher in group B compared to group A (p = 0.008). CONCLUSIONS: A hyaluronan-based mesh plays a role in promoting osteoblastic activity. Hyalonect(®) is suitable for restoring tissue continuity whenever the periosteal membrane is structurally impaired or inadequate. Our results demonstrated that, during early-phase bone healing, osteoblastic activity was increased in bone defect sites when a hyaluronan-based mesh was also used. The most important aspect of this study concerns its scintigraphy-based design. This study is the first to use a scintigraphic method to demonstrate the effectiveness of hyaluronic acid-based material for bone healing. BioMed Central 2016-05-03 /pmc/articles/PMC4855359/ /pubmed/27142755 http://dx.doi.org/10.1186/s13018-016-0393-y Text en © Mermerkaya et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mermerkaya, Musa Uğur
Doral, Mahmut Nedim
Karaaslan, Fatih
Huri, Gazi
Karacavuş, Seyhan
Kaymaz, Burak
Alkan, Erkan
Scintigraphic evaluation of the osteoblastic activity of rabbit tibial defects after HYAFF11 membrane application
title Scintigraphic evaluation of the osteoblastic activity of rabbit tibial defects after HYAFF11 membrane application
title_full Scintigraphic evaluation of the osteoblastic activity of rabbit tibial defects after HYAFF11 membrane application
title_fullStr Scintigraphic evaluation of the osteoblastic activity of rabbit tibial defects after HYAFF11 membrane application
title_full_unstemmed Scintigraphic evaluation of the osteoblastic activity of rabbit tibial defects after HYAFF11 membrane application
title_short Scintigraphic evaluation of the osteoblastic activity of rabbit tibial defects after HYAFF11 membrane application
title_sort scintigraphic evaluation of the osteoblastic activity of rabbit tibial defects after hyaff11 membrane application
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855359/
https://www.ncbi.nlm.nih.gov/pubmed/27142755
http://dx.doi.org/10.1186/s13018-016-0393-y
work_keys_str_mv AT mermerkayamusaugur scintigraphicevaluationoftheosteoblasticactivityofrabbittibialdefectsafterhyaff11membraneapplication
AT doralmahmutnedim scintigraphicevaluationoftheosteoblasticactivityofrabbittibialdefectsafterhyaff11membraneapplication
AT karaaslanfatih scintigraphicevaluationoftheosteoblasticactivityofrabbittibialdefectsafterhyaff11membraneapplication
AT hurigazi scintigraphicevaluationoftheosteoblasticactivityofrabbittibialdefectsafterhyaff11membraneapplication
AT karacavusseyhan scintigraphicevaluationoftheosteoblasticactivityofrabbittibialdefectsafterhyaff11membraneapplication
AT kaymazburak scintigraphicevaluationoftheosteoblasticactivityofrabbittibialdefectsafterhyaff11membraneapplication
AT alkanerkan scintigraphicevaluationoftheosteoblasticactivityofrabbittibialdefectsafterhyaff11membraneapplication